Girard Partners Ltd. Johnson & Johnson Transaction History

Girard Partners Ltd.

$1.06 Billion
Q2 2024

A detailed history of Girard Partners Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Girard Partners Ltd. holds 21,976 shares of JNJ stock, worth $3.42 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

21,976

Previous 22,967 4.31%

Holding current value

$3.42 Million

Previous $3.63 Million 11.59%

% of portfolio

0.3%

Previous 0.34%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $143,080 - $156,359	-991 Reduced 4.31%	21,976 $3.21 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $532,715 - $558,523	3,432 Added 17.57%	22,967 $3.63 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $303,576 - $331,264	-2,085 Reduced 9.64%	19,535 $3.06 Million
Q3 2023 Nov 02, 2023	SELL	$155.75 - $174.48 $271,628 - $304,293	-1,744 Reduced 7.46%	21,620 $3.37 Million
Q2 2023 Aug 15, 2023	BUY	$154.35 - $166.11 $20,837 - $22,424	135 Added 0.58%	23,364 $3.87 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $971,251 - $1.16 Million	-6,430 Reduced 21.68%	23,229 $3.6 Million
Q4 2022 Jan 26, 2023	SELL	$160.2 - $179.79 $89,712 - $100,682	-560 Reduced 1.85%	29,659 $0
Q3 2022 Oct 20, 2022	SELL	$161.33 - $179.52 $561,589 - $624,909	-3,481 Reduced 10.33%	30,219 $4.94 Million
Q2 2022 Jul 26, 2022	SELL	$168.19 - $186.01 $341,089 - $377,228	-2,028 Reduced 5.68%	33,700 $5.98 Million
Q1 2022 Apr 27, 2022	SELL	$158.14 - $179.59 $2.84 Million - $3.22 Million	-17,951 Reduced 33.44%	35,728 $6.33 Million
Q4 2021 Feb 02, 2022	BUY	$155.93 - $173.01 $4,989 - $5,536	32 Added 0.06%	53,679 $9.18 Million
Q3 2021 Nov 01, 2021	BUY	$161.5 - $179.47 $7.26 Million - $8.07 Million	44,983 Added 519.19%	53,647 $8.66 Million
Q3 2021 Nov 01, 2021	SELL	$161.5 - $179.47 $6.92 Million - $7.69 Million	-42,851 Reduced 83.18%	8,664 $8.66 Million
Q2 2021 Aug 10, 2021	SELL	$159.48 - $171.07 $8,771 - $9,408	-55 Reduced 0.11%	51,515 $8.49 Million
Q1 2021 May 06, 2021	SELL	$153.07 - $170.48 $10,867 - $12,104	-71 Reduced 0.14%	51,570 $8.48 Million
Q4 2020 Feb 02, 2021	SELL	$137.11 - $157.38 $219,787 - $252,280	-1,603 Reduced 3.01%	51,641 $8.13 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $591,140 - $647,778	-4,211 Reduced 7.33%	53,244 $7.93 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $603,346 - $728,408	-4,684 Reduced 7.54%	57,455 $8.08 Million
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $75,686 - $104,867	681 Added 1.11%	62,139 $8.15 Million
Q4 2019 Feb 03, 2020	SELL	$127.5 - $146.44 $6,247 - $7,175	-49 Reduced 0.08%	61,458 $9.07 Million
Q3 2019 Nov 01, 2019	SELL	$126.95 - $142.14 $687,815 - $770,114	-5,418 Reduced 8.1%	61,507 $7.96 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $10,229 - $11,250	78 Added 0.12%	66,925 $9.32 Million
Q1 2019 May 08, 2019	BUY	$125.72 - $139.79 $20,869 - $23,205	166 Added 0.25%	66,847 $9.34 Million
Q4 2018 Feb 11, 2019	SELL	$122.84 - $147.84 $207,845 - $250,145	-1,692 Reduced 2.47%	66,681 $8.61 Million
Q3 2018 Nov 09, 2018	SELL	$121.58 - $142.88 $2.03 Million - $2.38 Million	-16,656 Reduced 19.59%	68,373 $9.45 Million
Q2 2018 Aug 07, 2018	BUY	$119.4 - $131.76 $61,132 - $67,461	512 Added 0.61%	85,029 $10.3 Million
Q1 2018 Apr 18, 2018	BUY	$125.1 - $148.14 $275,595 - $326,352	2,203 Added 2.68%	84,517 $10.8 Million
Q4 2017 Feb 07, 2018	BUY	$131.22 - $143.62 $31,099 - $34,037	237 Added 0.29%	82,314 $11.5 Million
Q3 2017 Nov 08, 2017	SELL	$129.47 - $135.38 $19,032 - $19,900	-147 Reduced 0.18%	82,077 $10.7 Million
Q2 2017 Aug 08, 2017	BUY	N/A	82,224	82,224 $10.9 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Account

Girard Partners Ltd. Johnson & Johnson Transaction History